Ben Goldacre, The Guardian, Saturday 28 August 2010
For simpletons and amateurs, there are good research methods, and bad research methods. In reality, different tools are valuable in different situations, and sometimes, even very tiny numbers of people can give you a meaningful piece of information: even an anecdote can be informative. Read the rest of this entry »
Ben Goldacre, The Guardian, Saturday 21 August 2010
Pass rates are at 98%. A quarter of grades are higher than an A. This week every newspaper in the country was filled with people asserting that exams are definitely getting easier, and then other people asserting that exams are definitely not getting easier. The question for me is always simple: how do you know?
Ben Goldacre, The Guardian, Saturday 14 August 2010
This week the drug company AstraZeneca paid out £125m to settle a class action. Over 17,500 patients claim the company withheld information showing that schizophrenia drug quetiapine (tradename Seroquel) might cause diabetes. Why do companies pay out money before cases get to court?
Ben Goldacre, The Guardian, Saturday 7 August 2010
According to the Home Office this week, Sarah’s law – where any parent can find out if any adult in contact with their child has a record of violent or sexual crimes – has “already protected more than 60 children from abuse during its pilot“. This fact was widely reported and was the headline finding. As the Sun said: “More than 60 sickening offences were halted by Sarah’s Law during its trial”. Read the rest of this entry »
Ben Goldacre, The Guardian, Saturday 31 July 2010
It’s the near misses that really make you want to shoot your own face off. This week the Centre for Policy Studies has published a pamphlet on education which has been covered by the Mirror, the Mail, the BBC, the Telegraph, the Express, the Guardian, and more. Boris Johnson endorses it.
I zipped off this quick podcast from my phone on Monday and put it on my secondary blog, which I run for scrappy stuff. People seemed to like it a bit so I’m reposting here. There’s more audio stuff coming, a bit of video too, and I’ll work out good feeds and iTunes stuff over the next couple of weeks. Cheery pip.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Ben Goldacre, The Guardian, Saturday 24 July 2010
There is a pleasing symmetry in the ropey science you get from different players. When GlaxoSmithKline are confronted with an unflattering meta-analysis summarising the results of all 56 trials on one of their treatments, as we saw last week, their defense is to point at 7 positive trials, exactly as a homeopath would do. Politicians will often find a ray of positive sunshine in a failed policy’s appraisal, and promote that to the sky. Newspapers, similarly, will spin science to fit their political agenda, with surreal consequences (the Telegraph have claimed recently that shopping causes infertility in men, and the Daily Mail reckon housework prevents breast cancer in women).
But does the same thing happen in formal academic research?
Ben Goldacre, The Guardian, Monday 19 July 2010
What do you do, as a campaigner for libel reform, when a litigious millionaire calls you a liar? This ethical quandary was presented to me last week when twitter account of Gillian McKeith – or to give her full medical title, “Gillian McKeith” – called my book “lies”. Read the rest of this entry »
Ben Goldacre, The Guardian, Saturday 17 July 2010
This week the FDA voted not to ban GlaxoSmithKline’s diabetes drug rosiglitazone (brand name Avandia). Their vote has been reported as a victory for the company. I don’t think so: this saga tells an ugly story about our collective medical incompetence.
Ben Goldacre, The Guardian, Saturday 10 July 2010
This week the food and nutrition pills industries are complaining. They like to make health claims about their products, which often turn out to be unsupported by the evidence. Regulating that mess would be tedious and long-winded, the kind of project enjoyed by the EU, and so the Nutrition and Health Claims Regulation was brought in during 2006. Since then, member states have submitted tens of thousands of health claims on behalf of manufacturers about cranberries, fish oil, and every magical ingredient you can think of. This week it turned out that 900 have been examined so far, of which 80% have unsurprisingly been rejected. Read the rest of this entry »
